Literature DB >> 22843098

Mitotic failures in cancer: Aurora B kinase and its potential role in the development of aneuploidy.

Katalin Hegyi1, Gábor Méhes.   

Abstract

One of the basic requirements during the process of cell division is to maintain genetic integrity and ensure normal ploidy. The family of Aurora kinases, composed of Aurora A, B and C, takes a major role in the control of centrosome cycle, mitotic entry, chromosome condensation and coordination of chromosomal movements. Deregulation of kinase expression was described in a series of different malignancies which was also associated with aneuploidy. Recently, Aurora kinases gained significant interest as potential therapeutic targets in oncology. While there is increasing evidence about the activities of Aurora A kinase during cancer progression, data are controversial regarding the role of Aurora B. In this review the biology of Aurora kinases and its potential relation to cancer progression is discussed with special focus on functional changes and determination of Aurora B kinase.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22843098     DOI: 10.1007/s12253-012-9534-8

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  110 in total

1.  CENP-A phosphorylation by Aurora-A in prophase is required for enrichment of Aurora-B at inner centromeres and for kinetochore function.

Authors:  Naoko Kunitoku; Takashi Sasayama; Tomotoshi Marumoto; Dongwei Zhang; Shinobu Honda; Osamu Kobayashi; Katsuyoshi Hatakeyama; Yukitaka Ushio; Hideyuki Saya; Toru Hirota
Journal:  Dev Cell       Date:  2003-12       Impact factor: 12.270

2.  Deregulation of Aurora kinase gene expression in human testicular germ cell tumours.

Authors:  E Baldini; Y Arlot-Bonnemains; M Mottolese; S Sentinelli; B Antoniani; S Sorrenti; M Salducci; E Comini; S Ulisse; M D'Armiento
Journal:  Andrologia       Date:  2010-08       Impact factor: 2.775

3.  Aurora-C kinase supports mitotic progression in the absence of Aurora-B.

Authors:  Scott D Slattery; Michael A Mancini; Bill R Brinkley; Rebecca M Hall
Journal:  Cell Cycle       Date:  2009-09-21       Impact factor: 4.534

4.  Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases.

Authors:  Claudia Crosio; Gian Maria Fimia; Romain Loury; Masashi Kimura; Yukio Okano; Hongyi Zhou; Subrata Sen; C David Allis; Paolo Sassone-Corsi
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

5.  Phosphorylation of mammalian Sgo2 by Aurora B recruits PP2A and MCAK to centromeres.

Authors:  Yuji Tanno; Tomoya S Kitajima; Takashi Honda; Yasuto Ando; Kei-Ichiro Ishiguro; Yoshinori Watanabe
Journal:  Genes Dev       Date:  2010-10-01       Impact factor: 11.361

6.  Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation.

Authors:  Hidemasa Goto; Yoshihiro Yasui; Erich A Nigg; Masaki Inagaki
Journal:  Genes Cells       Date:  2002-01       Impact factor: 1.891

7.  Mitotic kinase Aurora-A phosphorylates RASSF1A and modulates RASSF1A-mediated microtubule interaction and M-phase cell cycle regulation.

Authors:  R Rong; L Y Jiang; M S Sheikh; Y Huang
Journal:  Oncogene       Date:  2007-06-11       Impact factor: 9.867

8.  Phosphorylation of the par polarity complex protein Par3 at serine 962 is mediated by aurora a and regulates its function in neuronal polarity.

Authors:  Mohammad R Khazaei; Andreas W Püschel
Journal:  J Biol Chem       Date:  2009-10-06       Impact factor: 5.157

9.  Expression of Aurora kinases in human thyroid carcinoma cell lines and tissues.

Authors:  Salvatore Ulisse; Jean-Guy Delcros; Enke Baldini; Matteo Toller; Francesco Curcio; Laura Giacomelli; Claude Prigent; Francesco S Ambesi-Impiombato; Massimino D'Armiento; Yannick Arlot-Bonnemains
Journal:  Int J Cancer       Date:  2006-07-15       Impact factor: 7.396

10.  The chromosome passenger complex is required for fidelity of chromosome transmission and cytokinesis in meiosis of mouse oocytes.

Authors:  Bedra Sharif; Jie Na; Karin Lykke-Hartmann; Stephen H McLaughlin; Ernest Laue; David M Glover; Magdalena Zernicka-Goetz
Journal:  J Cell Sci       Date:  2010-12-15       Impact factor: 5.285

View more
  7 in total

1.  Mutant KRAS Status Is Associated with Increased KRAS Copy Number Imbalance: a Potential Mechanism of Molecular Heterogeneity.

Authors:  Ottó Dócs; Katalin Hegyi; Attila Mokánszky; Anikó Mónusné; Lívia Beke; Csilla András; Judit Bedekovics; Gábor Méhes
Journal:  Pathol Oncol Res       Date:  2016-10-15       Impact factor: 3.201

2.  Investigating Transcriptional Dynamics Changes and Time-Dependent Marker Gene Expression in the Early Period After Skeletal Muscle Injury in Rats.

Authors:  Kang Ren; Liangliang Wang; Liang Wang; Qiuxiang Du; Jie Cao; Qianqian Jin; Guoshuai An; Na Li; Lihong Dang; Yingjie Tian; Yingyuan Wang; Junhong Sun
Journal:  Front Genet       Date:  2021-06-17       Impact factor: 4.599

3.  EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspases.

Authors:  Hem Chandra Jha; Jie Lu; Abhik Saha; Qiliang Cai; Shuvomoy Banerjee; Mahadesh A J Prasad; Erle S Robertson
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

4.  AMG 900, a potent inhibitor of aurora kinases causes pharmacodynamic changes in p-Histone H3 immunoreactivity in human tumor xenografts and proliferating mouse tissues.

Authors:  Gloria Juan; Tammy L Bush; Connie Ma; Raffi Manoukian; Grace Chung; Jennifer M Hawkins; Stephen Zoog; Richard Kendall; Robert Radinsky; Robert Loberg; Greg Friberg; Marc Payton
Journal:  J Transl Med       Date:  2014-11-04       Impact factor: 5.531

5.  Multipolar mitosis and aneuploidy after chrysotile treatment: a consequence of abscission failure and cytokinesis regression.

Authors:  Beatriz Araujo Cortez; Paula Rezende-Teixeira; Sambra Redick; Stephen Doxsey; Glaucia Maria Machado-Santelli
Journal:  Oncotarget       Date:  2016-02-23

Review 6.  Histone Modifications and Their Targeting in Lymphoid Malignancies.

Authors:  Miranda Fernández-Serrano; René Winkler; Juliana C Santos; Marguerite-Marie Le Pannérer; Marcus Buschbeck; Gaël Roué
Journal:  Int J Mol Sci       Date:  2021-12-27       Impact factor: 5.923

7.  An Aurora kinase inhibitor, AMG900, inhibits glioblastoma cell proliferation by disrupting mitotic progression.

Authors:  Jaewook Ryu; Jaehyuk Pyo; Chang-Woo Lee; Ja-Eun Kim
Journal:  Cancer Med       Date:  2018-09-17       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.